• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入住重症监护病房的重症血液系统恶性肿瘤患者的临床结局及生存决定因素

Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness.

作者信息

Singh Suvir, Sharma Rintu, Singh Jagdeep, Jain Kunal, Kaur Gurkirat, Gupta Vivek, Gautam P L

机构信息

Department of Clinical Hematology and Stem Cell Transplantation, Bone Marrow Transplantation, Dayanand Medical College and Hospital, Ludhiana, Punjab 141001 India.

Department of Medical Oncology, Dayanand Medical College and Hospital, Ludhiana, India.

出版信息

Indian J Hematol Blood Transfus. 2024 Jul;40(3):423-431. doi: 10.1007/s12288-024-01757-3. Epub 2024 Mar 25.

DOI:10.1007/s12288-024-01757-3
PMID:39011248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11246339/
Abstract

UNLABELLED

Outcomes of patients with hematologic malignancies requiring ICU care for critical illness are suboptimal and represent a major unmet need in this population. We present data from a dedicated haematology oncology setting including 63 patients with a median age of 60 years admitted to the ICU for critical illness with organ dysfunction. The most common underlying diagnosis was multiple myeloma (30%) followed by acute myeloid leukemia (25%). Chemotherapy had been initiated for 90.7% patients before ICU admission. The most common indication for ICU care was respiratory failure (36.5%) and shock (17.5%) patients. Evidence of sepsis was present in 44 (69%) patients. After shifting to ICU, 32 (50%) patients required inotropic support and 18 (28%) required invasive mechanical ventilation. After a median of 5 days of ICU stay, 43.1% patients had died, most commonly due to multiorgan dysfunction. Risk of mortality was higher with involvement of more than two major organs ( = .001), underlying AML ( = .001), need for mechanical ventilation ( = .001) and high inotrope usage ( = .004). Neutropenia was not associated with mortality. Our study indicates high rates of short term mortality and defines prognostic factors which can be used to prognosticate patients and establish goals of care.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s12288-024-01757-3.

摘要

未标注

需要重症监护病房(ICU)护理的血液系统恶性肿瘤患者的预后不理想,是这一人群中尚未满足的主要需求。我们展示了来自专门血液肿瘤科室的数据,包括63名因器官功能障碍而入住ICU进行重症治疗的患者,中位年龄为60岁。最常见的潜在诊断是多发性骨髓瘤(30%),其次是急性髓系白血病(25%)。90.7%的患者在入住ICU前已开始化疗。入住ICU最常见的指征是呼吸衰竭(36.5%)和休克(17.5%)患者。44名(69%)患者有脓毒症证据。转入ICU后,32名(50%)患者需要使用血管活性药物支持,18名(28%)患者需要有创机械通气。在ICU中位住院5天后,43.1%的患者死亡,最常见的原因是多器官功能障碍。涉及两个以上主要器官(P = 0.001)、潜在的急性髓系白血病(P = 0.001)、需要机械通气(P = 0.001)和高剂量血管活性药物使用(P = 0.004)时,死亡风险更高。中性粒细胞减少与死亡率无关。我们的研究表明短期死亡率很高,并确定了可用于预测患者预后和确立治疗目标的预后因素。

补充信息

在线版本包含可在10.1007/s12288-024-01757-3获取的补充材料。

相似文献

1
Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness.入住重症监护病房的重症血液系统恶性肿瘤患者的临床结局及生存决定因素
Indian J Hematol Blood Transfus. 2024 Jul;40(3):423-431. doi: 10.1007/s12288-024-01757-3. Epub 2024 Mar 25.
2
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
3
Prescribed hypocaloric nutrition support for critically-ill adults.为重症成年患者开具低热量营养支持方案。
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD007867. doi: 10.1002/14651858.CD007867.pub2.
4
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings.**用于** ICU 成人患者的意识模糊评估方法(CAM-ICU)**用于** 诊断重症监护环境下成人的意识障碍。
Cochrane Database Syst Rev. 2023 Nov 21;11(11):CD013126. doi: 10.1002/14651858.CD013126.pub2.
5
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.影响重症成人和儿童机械通气撤机方案使用的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2.
6
Early versus late tracheostomy in critically ill COVID-19 patients.危重症 COVID-19 患者的早期与晚期气管切开术。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD015532. doi: 10.1002/14651858.CD015532.
7
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.对重症监护病房中的成年重症患者进行早期干预(活动或主动锻炼)。
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.
10
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.对于接受强化化疗或放疗或两者联合治疗、有或没有造血干细胞支持的血液系统恶性肿瘤患者,采用限制性与宽松性红细胞输血策略的比较。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2.

本文引用的文献

1
The predictive value of the modified early warning score for admission to the intensive care unit in patients with a hematologic malignancy - A multicenter observational study.改良早期预警评分对血液系统恶性肿瘤患者入住重症监护病房的预测价值——一项多中心观察性研究。
Intensive Crit Care Nurs. 2023 Dec;79:103486. doi: 10.1016/j.iccn.2023.103486. Epub 2023 Jul 11.
2
Real-world challenges in the management of acute myeloid leukemia: a single-center experience from North India.真实世界中急性髓细胞白血病管理面临的挑战:来自印度北部某单一中心的经验。
Ann Hematol. 2022 Jun;101(6):1261-1273. doi: 10.1007/s00277-022-04814-x. Epub 2022 Mar 24.
3
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections.血液恶性肿瘤患者的抗生素管理:从预防到不常见感染。
Curr Oncol Rep. 2022 Jul;24(7):835-842. doi: 10.1007/s11912-022-01226-y. Epub 2022 Mar 22.
4
Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India: A Cross-sectional Study.印度重症监护病房成年患者脓毒症患病率及转归的估计:一项横断面研究。
Chest. 2022 Jun;161(6):1543-1554. doi: 10.1016/j.chest.2021.12.673. Epub 2022 Jan 31.
5
Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria.根据脓毒症-3标准定义的血液系统恶性肿瘤合并感染性休克患者28天死亡率的结局及预测因素
J Natl Compr Canc Netw. 2022 Jan;20(1):45-53. doi: 10.6004/jnccn.2021.7046.
6
Critical illness in patients with hematologic malignancy: a population-based cohort study.血液恶性肿瘤患者的危重病:基于人群的队列研究。
Intensive Care Med. 2021 Oct;47(10):1104-1114. doi: 10.1007/s00134-021-06502-2. Epub 2021 Sep 14.
7
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.KDIGO 2021慢性肾脏病血压管理临床实践指南
Kidney Int. 2021 Mar;99(3S):S1-S87. doi: 10.1016/j.kint.2020.11.003.
8
Epidemiology, Clinical Characteristics, and Prognostic Factors in Critically Ill Patients with Hematolymphoid Malignancy.血液淋巴系统恶性肿瘤重症患者的流行病学、临床特征及预后因素
Indian J Crit Care Med. 2021 Jan;25(1):56-61. doi: 10.5005/jp-journals-10071-23469.
9
Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.维奈托克与阿扎胞苷(VenAZA)联合疗法用于年轻、身体状况不佳的急性髓系白血病患者:来自一个发展中国家的观点
Leuk Lymphoma. 2021 Jun;62(6):1514-1517. doi: 10.1080/10428194.2020.1867724. Epub 2021 Jan 15.
10
Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit.在重症监护病房监测的发热性中性粒细胞减少症患者中,死亡率与 SOFA、qSOFA、MASCC 评分之间关系的确定。
Support Care Cancer. 2021 Jul;29(7):4089-4094. doi: 10.1007/s00520-020-05924-w. Epub 2021 Jan 6.